newsfilter
← Latest News
GlobeNewswire·

Adagio Therapeutics Provides Update on Timing of Adintrevimab EUA Request

WALTHAM, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (NASDAQ:ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases, rece